title: In anticipation of International Stroke Trial-3 (IST-3).
authors.affiliation: Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA. lydenp@cshs.org
authors.forename: Patrick D
authors.initials: PD
authors.lastname: Lyden
mesh_terms: D000933:Antifibrinolytic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D018696:Neuroprotective Agents / Q000008:administration & dosage; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
chemical_list: D000933:Antifibrinolytic Agents; D018696:Neuroprotective Agents; D010959:Tissue Plasminogen Activator